ORAMED PHARMACEUTICALS INC. Quarterly Revenues in USD from Q1 2016 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Oramed Pharmaceuticals Inc. annual/quarterly Revenues history and growth rate from Q1 2016 to Q2 2023.
  • Oramed Pharmaceuticals Inc. Revenues for the quarter ending June 30, 2023 was $674K, unchanged year-over-year.
  • Oramed Pharmaceuticals Inc. Revenues for the twelve months ending June 30, 2023 was $2.93M, unchanged year-over-year.
  • Oramed Pharmaceuticals Inc. annual Revenues for 2023 was $1.34M, a 50.4% decline from 2022.
  • Oramed Pharmaceuticals Inc. annual Revenues for 2022 was $2.7M, unchanged from 2021.
  • Oramed Pharmaceuticals Inc. annual Revenues for 2021 was $2.7M, a 0.26% decline from 2020.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $2.93M $674K $0 0% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $2.93M $666K $0 0% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $2.93M $904K $0 0% Sep 1, 2022 Dec 31, 2022 10-K 2023-03-06
Q3 2022 $2.93M $682K $0 0% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $2.93M $674K $0 0% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $2.93M $666K $0 0% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $2.93M $904K $0 0% Sep 1, 2021 Dec 31, 2021 10-QT 2022-03-30
Q3 2021 $2.93M $682K +$1K +0.15% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $2.93M $674K -$7K -1.03% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 $2.93M $666K -$8K -1.19% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $2.94M $904K +$230K +34.1% Sep 1, 2020 Dec 31, 2020 10-QT 2022-03-30
Q3 2020 $2.71M $681K $0 0% Jun 1, 2020 Aug 31, 2020 10-K 2021-11-24
Q2 2020 $2.71M $681K -$1K -0.15% Mar 1, 2020 May 31, 2020 10-Q 2021-07-14
Q1 2020 $2.71M $674K +$8K +1.2% Dec 1, 2019 Feb 29, 2020 10-Q 2021-04-13
Q4 2019 $2.7M $674K $0 0% Sep 1, 2019 Nov 30, 2019 10-Q 2021-01-14
Q3 2019 $2.7M $681K +$64K +10.4% Jun 1, 2019 Aug 31, 2019 10-K 2020-11-24
Q2 2019 $2.64M $682K +$65K +10.5% Mar 1, 2019 May 31, 2019 10-Q 2020-07-07
Q1 2019 $2.57M $666K +$62K +10.3% Dec 1, 2018 Feb 28, 2019 10-Q 2020-04-06
Q4 2018 $2.51M $674K +$63K +10.3% Sep 1, 2018 Nov 30, 2018 10-Q 2020-01-09
Q3 2018 $2.45M $617K -$1K -0.16% Jun 1, 2018 Aug 31, 2018 10-K 2019-11-27
Q2 2018 $2.45M $617K $0 0% Mar 1, 2018 May 31, 2018 10-Q 2019-07-10
Q1 2018 $2.45M $604K -$7K -1.15% Dec 1, 2017 Feb 28, 2018 10-Q 2019-04-10
Q4 2017 $2.46M $611K +$1K +0.16% Sep 1, 2017 Nov 30, 2017 10-Q 2019-01-14
Q3 2017 $2.46M $618K Jun 1, 2017 Aug 31, 2017 10-K 2019-11-27
Q2 2017 $617K +$780K Mar 1, 2017 May 31, 2017 10-Q 2018-07-12
Q1 2017 $611K +$486K +389% Dec 1, 2016 Feb 28, 2017 10-Q 2018-04-09
Q4 2016 $610K Sep 1, 2016 Nov 30, 2016 10-Q 2018-01-11
Q2 2016 -$163K Mar 1, 2016 May 31, 2016 10-Q 2017-07-06
Q1 2016 $125K Dec 1, 2015 Feb 29, 2016 10-Q 2017-04-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.